MwanzoRGLS • NASDAQ
add
Regulus Therapeutics Inc
$ 8.22
Baada ya Saa za Kazi:(0.12%)-0.010
$ 8.21
Imefungwa: 6 Jun, 17:42:27 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 8.10
Bei za siku
$ 8.07 - $ 8.28
Bei za mwaka
$ 0.83 - $ 8.28
Thamani ya kampuni katika soko
569.10M USD
Wastani wa hisa zilizouzwa
2.38M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 3.72M | 33.49% |
Mapato halisi | -9.63M | -13.76% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.15 | 48.28% |
EBITDA | -10.45M | -19.53% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 65.37M | -32.99% |
Jumla ya mali | 74.83M | -34.44% |
Jumla ya dhima | 5.80M | -11.48% |
Jumla ya hisa | 69.03M | — |
hisa zilizosalia | 69.23M | — |
Uwiano wa bei na thamani | 7.79 | — |
Faida inayotokana na mali | -33.14% | — |
Faida inayotokana mtaji | -35.63% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -9.63M | -13.76% |
Pesa kutokana na shughuli | -10.61M | -21.40% |
Pesa kutokana na uwekezaji | 21.50M | 127.37% |
Pesa kutokana na ufadhili | elfu 45.00 | -99.95% |
Mabadiliko halisi ya pesa taslimu | 10.93M | 87.87% |
Mtiririko huru wa pesa | -6.34M | -1.31% |
Kuhusu
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. In April 2025, Novartis announced that it had entered into an agreement to acquire Regulus. Wikipedia
Ilianzishwa
Sep 2007
Tovuti
Wafanyakazi
34
